|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEW |
I Quesada, Instituto de Bioingenieria, Universidad Miguel Hernandez, Elche, Spain
E Tuduri, Instituto de Bioingenieria, Universidad Miguel Hernandez, Elche, Spain
C Ripoll, Instituto de Bioingenieria, Universidad Miguel Hernandez, Elche, Spain
A Nadal, Instituto de Bioingenieria, Universidad Miguel Hernandez, Elche, Spain
Correspondence: Ivan Quesada, Email: ivanq{at}umh.es
Abstract
The secretion of glucagon by pancreatic alpha-cells plays a critical role in the regulation of glycaemia. This hormone counteracts hypoglycaemia and opposes to insulin actions by stimulating hepatic glucose synthesis and mobilization, thereby increasing blood glucose concentrations. During the last decade, knowledge of alpha-cell physiology has greatly improved, especially concerning molecular and cellular mechanisms. In this review we have addressed recent findings on alpha-cell physiology and the regulation of ion channels, electrical activity, calcium signals and glucagon release. Our focus in this paper has been the multiple control levels that modulate glucagon secretion from glucose and nutrients to paracrine and neural inputs. Additionally, we have described the glucagon actions on glycaemia and energy metabolism, and discussed their involvement in the pathophysiology of diabetes. Finally, some of the current approaches for diabetes therapy related to alpha-cell function are also discussed in this review. A better understanding of the alpha-cell physiology is necessary for an integral comprehension of the regulation of glucose homeostasis and the development of diabetes.
This article has been cited by other articles:
![]() |
R. P. A. Barros, C. Gabbi, A. Morani, M. Warner, and J.-A. Gustafsson Participation of ER{alpha} and ER{beta} in glucose homeostasis in skeletal muscle and white adipose tissue Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E124 - E133. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tuduri, L. Marroqui, S. Soriano, A. B. Ropero, T. M. Batista, S. Piquer, M. A. Lopez-Boado, E. M. Carneiro, R. Gomis, A. Nadal, et al. Inhibitory Effects of Leptin on Pancreatic {alpha}-Cell Function Diabetes, July 1, 2009; 58(7): 1616 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ahren {beta}- and {alpha}-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance: Outcome of a 12-Year Prospective Study in Postmenopausal Caucasian Women Diabetes, March 1, 2009; 58(3): 726 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ali and D. J. Drucker Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E415 - E421. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Quoix, R. Cheng-Xue, L. Mattart, Z. Zeinoun, Y. Guiot, M. C. Beauvois, J.-C. Henquin, and P. Gilon Glucose and Pharmacological Modulators of ATP-Sensitive K+ Channels Control [Ca2+]c by Different Mechanisms in Isolated Mouse {alpha}-Cells Diabetes, February 1, 2009; 58(2): 412 - 421. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH |